期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
清心莲子饮治疗脾肾两虚型糖尿病肾病水肿 被引量:2
1
作者 高靖 《实用中医内科杂志》 2013年第5期116-117,共2页
清心莲子饮出自《太平惠民和剂局方》,由黄芩、麦门冬、地骨皮、炙甘草、莲子肉、白茯苓、车前子、黄芪、人参组成,具有清心火、交心肾、益气阴、止浊淋之功。遵循辨证施治原则,治疗脾肾两虚型糖尿病肾病水肿疗效满意。
关键词 糖尿病肾病 水肿 脾肾两虚型 清心莲子饮 中医药治疗 太平惠民和剂局方 证治准绳 素问 医方集解
原文传递
美国《糖尿病医学诊疗标准(2021)》与《中国老年糖尿病诊疗指南(2021)》的比较 被引量:11
2
作者 倪小清 韩丽珠 +4 位作者 尹琪楠 任智文 罗丹 边原 童荣生 《医药导报》 CAS 北大核心 2022年第10期1417-1422,共6页
老年糖尿病成为一种常见疾病,2021年中国颁布了《中国老年糖尿病诊疗指南(2021年版)》;鉴于医疗证据的变化,同年美国颁布《糖尿病医学诊疗标准-2021》,在以往基础上对糖尿病的诊疗进行了更新。该文将两部指南中关于老年糖尿病部分进行... 老年糖尿病成为一种常见疾病,2021年中国颁布了《中国老年糖尿病诊疗指南(2021年版)》;鉴于医疗证据的变化,同年美国颁布《糖尿病医学诊疗标准-2021》,在以往基础上对糖尿病的诊疗进行了更新。该文将两部指南中关于老年糖尿病部分进行对比解读,以期为诊治老年糖尿病的临床决策提供参考。 展开更多
关键词 美国糖尿病医学诊疗标准 中国老年糖尿病诊疗指南 糖尿病 指南
下载PDF
Impact Evaluation of CONSORT and STRICTA Guidelines on Reporting Quality for Randomized Controlled Trials of Acupuncture Conducted in China
3
作者 LU Li-ming HE Jun +3 位作者 ZENG Jing-chun LIAO Mu-xi JIA Chao PAN Hai-hua 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2017年第1期10-17,共8页
Objective: To evaluate and compare the reports' qualities of acupuncture randomized controlled trials (RCTs) conducted in China before and after the implementation of two guidelines, i.e., the Consolidated Standar... Objective: To evaluate and compare the reports' qualities of acupuncture randomized controlled trials (RCTs) conducted in China before and after the implementation of two guidelines, i.e., the Consolidated Standards of Reporting Trials (CONSORT) statement and the Standards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA). Methods: Proportions of studies that reported CONSORT and STRICTA items were compared for the years before and after implementation of these two guidelines. In addition, the total score of each item's reporting were calculated and reported differences during different date ranges were compared. Results: For CONSORT items (maximum score 8), there was evidence of a slight improvement in reporting between 1994-1995 and 1999-2000 combined (2.5 ± 0.6) and 2004-2006 and 2009-2010 combined (3.0 ± 0.9; difference 0.4, 95% confidence interval, 0.3 to 0.6, P〈0.01). For STRICTA items (maximum score 17), there was evidence that a slight improvement in reporting between 1994-1995 and 1999-2000 combined (8.6±2.1) and 2004-2005 and 2009-2010 combined (10.1 ±1.8; difference 1.5, 95% confidence interval, 1.1 to 1.9, P〈0.01). Conclusion: Quality of reporting for RCTs of acupuncture treatment conducted in China have generally improved since the introduction of the STRICTA and CONSORT guidelines. 展开更多
关键词 ACUPUNCTURE quality of reporting randomized controlled trials Consolidated standardsof Reporting Trials (CONSORT) statement Standards for Reporting Interventions in Controlled Trials ofAcupuncture (STRICTA)
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部